Literature DB >> 8734508

Survey of Ehrlichia canis antibodies among dogs in Israel.

G Baneth1, T Waner, A Koplah, S Weinstein, A Keysary.   

Abstract

A seroepidemiological survey was made of the prevalence of antibodies reactive with Ehrlichia canis in stray and pet dogs from five geographical regions of Israel. Serum samples from 410 dogs were assayed by an indirect fluorescent antibody test and serum reactive at a 1:20 dilution or greater was considered positive. The overall seroprevalence was 30 per cent with 23.9 per cent in pet dogs and 37.5 per cent in stray dogs. The seroprevalence in apparently healthy pets (17.6 per cent) was lower but did not differ significantly from the seroprevalence in sick animals (26.6 per cent). The seroprevalence was highest in the north of Israel and lowest in the central hilly area, and followed the same trend in both the populations sampled. Young dogs (under one year old) had a lower seroprevalence (14.9 per cent) than adult (one to eight years) (36.4 per cent) or older dogs (over eight years) (34.2 per cent). The results demonstrate that dogs in Israel are extensively exposed to E canis and indicate that ehrlichiosis is endemic in this area of the Middle East.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8734508     DOI: 10.1136/vr.138.11.257

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  8 in total

1.  Intraoperative bleeding in dogs from Grenada seroreactive to Anaplasma platys and Ehrlichia canis.

Authors:  M Lanza-Perea; U Zieger; B A Qurollo; B C Hegarty; E L Pultorak; S Kumthekar; R Bruhl-Day; E B Breitschwerdt
Journal:  J Vet Intern Med       Date:  2014-10-01       Impact factor: 3.333

2.  Amplification of ehrlichial DNA from dogs 34 months after infection with Ehrlichia canis.

Authors:  S Harrus; T Waner; I Aizenberg; J E Foley; A M Poland; H Bark
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

3.  Genetic and antigenic diversities of major immunoreactive proteins in globally distributed Ehrlichia canis strains.

Authors:  Xiaofeng Zhang; Tian Luo; Avi Keysary; Gad Baneth; Simone Miyashiro; Carmela Strenger; Trevor Waner; Jere W McBride
Journal:  Clin Vaccine Immunol       Date:  2008-05-14

Review 4.  Host surveys, ixodid tick biology and transmission scenarios as related to the tick-borne pathogen, Ehrlichia canis.

Authors:  R W Stich; John J Schaefer; William G Bremer; Glen R Needham; Sathaporn Jittapalapong
Journal:  Vet Parasitol       Date:  2008-09-12       Impact factor: 2.738

5.  Tick acquisition of Ehrlichia canis from dogs treated with doxycycline hyclate.

Authors:  John J Schaefer; Glen R Needham; William G Bremer; Yasuko Rikihisa; S A Ewing; R W Stich
Journal:  Antimicrob Agents Chemother       Date:  2007-07-02       Impact factor: 5.191

6.  Associated Factors to Seroprevalence of Ehrlichia spp. in Dogs of Quintana Roo, Mexico.

Authors:  Pedro Pablo Martínez-Vega; Manuel Emilio Bolio-Gonzalez; Roger Iván Rodríguez-Vivas; Eduardo Gutierrez-Blanco; Carlos Pérez-Osorio; Sandra Luz Villegas-Perez; Carlos Humberto Sauri-Arceo
Journal:  J Trop Med       Date:  2016-12-21

7.  Molecular detection of vector-borne pathogens in dogs and cats from Qatar.

Authors:  Ana Margarida Alho; Clara Lima; Maria Stefania Latrofa; Vito Colella; Silvia Ravagnan; Gioia Capelli; Luís Madeira de Carvalho; Luís Cardoso; Domenico Otranto
Journal:  Parasit Vectors       Date:  2017-06-20       Impact factor: 3.876

Review 8.  Diversity of Anaplasma and Ehrlichia/Neoehrlichia Agents in Terrestrial Wild Carnivores Worldwide: Implications for Human and Domestic Animal Health and Wildlife Conservation.

Authors:  Marcos Rogério André
Journal:  Front Vet Sci       Date:  2018-11-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.